Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Margarita Morozova"'
Autor:
Ibon Gutierro, Jordi Llaudó, Lourdes Anta, Mikhail Ivanov, Javier Martínez, Margarita Morozova, Ignacio Ayani, Juan Schronen
Publikováno v:
International clinical psychopharmacology. 31(6)
The aim of this study was to characterize the pharmacokinetics and to evaluate the safety of risperidone ISM in patients with schizophrenia or schizoaffective disorder after a single gluteal intramuscular injection at three different dose strengths (
Autor:
Margarita Morozova, Pilar Lim, David Hough, Mariëlle Eerdekens, Srihari Gopal, Ujjwala Vijapurkar
Publikováno v:
Schizophrenia Research. 116:107-117
We assessed efficacy and tolerability of the injectable atypical antipsychotic paliperidone palmitate in delaying time-to-relapse in adults with schizophrenia.Eligible patients (Positive and Negative Syndrome Scale [PANSS] total score120) were transi
Publikováno v:
Europe PubMed Central
There is a gap between theory and practice in treatment of acute schizophrenia. It could be visualized in relatively irrational treatment schemes and principles. In order to clarify the situation in Russia, we have analyzed antipsychotic treatment pa
Autor:
Margarita Morozova, Ge, Rupchev, Ig, Kozhekin, Tb, Arsenieva, Ra, Cheremin, Vn, Yachmenev, Ey, Onegina, Ak, Shvedova, Ag, Beniashvili, Ds, Burminsky, Ta, Lepilkina, Ss, Potanin
Publikováno v:
Europe PubMed Central
Our study was based on the hypothesis that a non competitive antagonist of NMDA receptors can improve clinical effects of antipsychotic therapy in a subgroup of patients with schizophrenia with clinical signs of glutamatergic hyperfunction such as ca
Publikováno v:
Europe PubMed Central
Publikováno v:
Europe PubMed Central
This paper was designed to report the results of analysis of metoprolol succinate substance and tablets obtained from two manufacturers, Akrikhin (Russia) and AstraZeneca (Sweden). The analysis was performed by spectroscopy in the near IR region and
Publikováno v:
Europe PubMed Central
A comparative study of the platelet resistance to different effects was conducted in patients with chronic schizophrenia and healthy controls using column chromatography on sepharose CL-2B with the incubation at 5 degrees C during 18 h. This method a
Autor:
Os, Brusov, Mi, Faktor, Gp, Zlobina, Am, Dupin, Ab, Katasonov, Ad, Dmitriev, Ev, Pavlova, Ag, Beniashvili, Margarita Morozova
Publikováno v:
Europe PubMed Central
A sample included 59 patients, 38 males and 21 females, mean age (M+/-SD) 33,4+/-10,2 years, age-at-onset 26+/-9,5 years, illness duration 7,8+/-6,1 years, with episodic progressive schizophrenia (ICD-10: schizophrenia, paranoid type, F20.0) with con
Autor:
Burbaeva GSh, Is, Boksha, Li, Starodubtseva, Ok, Savushkina, Eb, Tereshkina, Ms, Turishcheva, Ta, Prokhorova, Ea, Vorob Eva, Margarita Morozova
Publikováno v:
Europe PubMed Central
The glutamate-ergic hypothesis of schizophrenia pathogenesis has been substantially expanded due to recent data on changes in glutamate metabolizing enzymes (GME) in the brain of patients with schizophrenia. Significant changes in the amounts of glut
Autor:
Gi, Koliaskina, Tp, Sekirina, Lv, Androsova, Sg, Kushner, Ef, Vasil Eva, Oa, Burbaeva, Margarita Morozova
Publikováno v:
Europe PubMed Central
Humoral and cellular immunological parameters were studied in 59 schizophrenic patients and 38 healthy subjects. It was demonstrated that high level of circulating immune complexes is characteristic of the acute state (a relapse) of schizophrenia. Th